These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3307051)

  • 1. Hyperthermia for treatment of human split-thickness skin. Differential effects on HLA-DR-expressing cells and keratinocytes.
    Morhenn VB
    Transplantation; 1987 Aug; 44(2):280-6. PubMed ID: 3307051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-2 stimulates resting human T lymphocytes' response to allogeneic, gamma interferon-treated keratinocytes.
    Morhenn VB; Nickoloff BJ
    J Invest Dermatol; 1987 Nov; 89(5):464-8. PubMed ID: 3117903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of HLA antigens on renal tubular cells in culture. II. Effect of increased HLA antigen expression on tubular cell stimulation of lymphocyte activation and on their vulnerability to cell-mediated lysis.
    Bishop GA; Waugh JA; Hall BM
    Transplantation; 1988 Aug; 46(2):303-10. PubMed ID: 2970135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mixed epidermal cell-lymphocyte reaction. II. Epidermal Langerhans cells are responsible for the enhanced allogeneic lymphocyte-stimulating capacity of normal human epidermal cell suspensions.
    Sontheimer RD
    J Invest Dermatol; 1985 Jul; 85(1 Suppl):21s-26s. PubMed ID: 3159806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplification of T-cell response to PPD by epidermal cell suspensions containing HLA-DR-expressing keratinocytes.
    Tjernlund U; Scheynius A
    Scand J Immunol; 1987 Jul; 26(1):1-6. PubMed ID: 2441455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial class II antigen expression in cutaneous graft-versus-host disease.
    Beschorner WE; Farmer ER; Saral R; Stirling WL; Santos GW
    Transplantation; 1987 Aug; 44(2):237-43. PubMed ID: 3307048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Class II MHC antigen expression by human keratinocytes results from lympho-epidermal interactions and gamma-interferon production.
    Czernielewski JM; Bagot M
    Clin Exp Immunol; 1986 Nov; 66(2):295-302. PubMed ID: 2434272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of topical corticosteroid therapy on Langerhans cell antigen presenting function in human skin.
    Ashworth J; Booker J; Breathnach SM
    Br J Dermatol; 1988 Apr; 118(4):457-69. PubMed ID: 3288268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In cutaneous T-cell lymphoma, class II MHC molecules on CD1+ antigen-presenting cells are upregulated in involved compared with uninvolved epidermis.
    Hansen ER; Bang B; Larsen JK; Vejlsgaard GL; Baadsgaard O
    Br J Dermatol; 1994 Dec; 131(6):780-8. PubMed ID: 7531998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma interferon and tumor necrosis factor.
    Griffiths CE; Voorhees JJ; Nickoloff BJ
    J Am Acad Dermatol; 1989 Apr; 20(4):617-29. PubMed ID: 2497153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques.
    Gottlieb AB; Lifshitz B; Fu SM; Staiano-Coico L; Wang CY; Carter DM
    J Exp Med; 1986 Oct; 164(4):1013-28. PubMed ID: 2428913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defined in situ enumeration of T6 and HLA-DR expressing epidermal Langerhans cells: morphologic and methodologic aspects.
    de Jong MC; Blanken R; Nanninga J; Van Voorst Vader PC; Poppema S
    J Invest Dermatol; 1986 Dec; 87(6):698-702. PubMed ID: 2431069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of recombinant interleukin 1 and interleukin 2 on human keratinocytes.
    Morhenn VB; Wastek GJ; Cua AB; Mansbridge JN
    J Invest Dermatol; 1989 Jul; 93(1):121-6. PubMed ID: 2473134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Class II antigen expression by keratinocytes and enterocytes--an early feature of graft-versus-host-disease.
    Sviland L; Pearson AD; Eastham EJ; Green MA; Hamilton PJ; Proctor SJ; Malcolm AJ
    Transplantation; 1988 Sep; 46(3):402-6. PubMed ID: 2458641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant gamma interferon induces HLA-DR expression on squamous cell carcinoma, trichilemmoma, adenocarcinoma cell lines, and cultured human keratinocytes.
    Kameyama K; Tone T; Eto H; Takezaki S; Kanzaki T; Nishiyama S
    Arch Dermatol Res; 1987; 279(3):161-6. PubMed ID: 2439027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-DR-positive keratinocytes are associated with suppressor lymphocyte epidermotropism. A biomathematical study.
    Smolle J; Soyer HP; Juettner FM; Torne R; Stettner H; Kerl H
    Am J Dermatopathol; 1988 Apr; 10(2):128-32. PubMed ID: 2467574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synovial fluid mononuclear cells exhibit a spontaneous HLA-DR driven proliferative response.
    Duke O; Gordon Y; Panayi GS
    Clin Exp Immunol; 1987 Oct; 70(1):10-7. PubMed ID: 2961487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine combinations for induction of antigen-specific cytolytic T lymphocytes from peripheral blood lymphocytes.
    Tsujitani S; Nakashima M; Watanabe T; Kaibara N; Koprowski H; Steplewski Z
    Anticancer Res; 1995; 15(3):655-60. PubMed ID: 7645938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of HLA-DR antigen expression in phytohemagglutinin-activated T cells in man. Requirement of T cell recognition of self HLA-DR antigen expressed on the surface of monocytes.
    Moriya N; Sanjoh K; Yokoyama S; Hayashi T
    J Immunol; 1987 Nov; 139(10):3281-6. PubMed ID: 3500214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes.
    Tsujisaki M; Igarashi M; Sakaguchi K; Eisinger M; Herlyn M; Ferrone S
    J Immunol; 1987 Feb; 138(4):1310-6. PubMed ID: 3100635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.